ATP2A1 and myotonic dystrophy type 1: Furthermore, it reduced foci in the DM1 HeLa cell model and partially rescued misplicing of Clcn1 E7a and Atp2a1 E22 in the HSALR mouse model at a similar level observed with heptamidine, but without the associated toxicity (39).